Submit Deal

Peter Goldschmidt

Chairman and CEO at STADA ARZNEIMITTEL AG

Manager

Deal Bio

Total Deals7

Valued Deals3

Total Value£ 4.96 B

Avg. Deal Size£ 1.65 B

Market Context

Sort

01 Oct 2018|Germany|Pharmaceuticals

Target: STADA ARZNEIMITTEL AG

Bidder: BAIN CAPITAL LP

10 Service Providers

2 Target | 8 Bidder

37 Dealmakers

3 Target | 61 Bidder

£ 1.56 B

Value

10 Aug 2017|Germany|Pharmaceuticals

Target: STADA ARZNEIMITTEL AG

Bidder: BAIN CAPITAL LP

30 Service Providers

6 Target | 24 Bidder

65 Dealmakers

20 Target | 73 Bidder

£ 2.89 B

Value

04 Nov 2019|Czechia|Pharmaceuticals

Target: WALMARK

Bidder: CINVEN LTD

15 Service Providers

1 Target | 7 Bidder | 7 Vendor

18 Dealmakers

1 Target | 9 Bidder | 8 Vendor

n/a

Value

05 Nov 2019|Russian Federation|Pharmaceuticals

Target: TAKEDA PHARMACEUTICAL COMPANY LIMITED (OTC PORTFOLIO)

Bidder: STADA ARZNEIMITTEL AG

8 Service Providers

5 Bidder | 3 Vendor

37 Dealmakers

11 Bidder | 26 Vendor

£ 512 M

Value

02 Dec 2019|Ukraine|Pharmaceuticals

Target: BIOPHARMA (PHARMACEUTICALS UNIT)

Bidder: STADA ARZNEIMITTEL AG

3 Service Providers

1 Bidder | 2 Vendor

5 Dealmakers

3 Bidder | 2 Vendor

n/a

Value

24 Feb 2020|United Kingdom|Medical Supplies

Target: GLAXOSMITHKLINE (OTC BRAND PORTFOLIO)

Bidder: STADA ARZNEIMITTEL AG

3 Service Providers

1 Bidder | 2 Vendor

5 Dealmakers

2 Bidder | 3 Vendor

n/a

Value

12 Jul 2023|France|Pharmaceuticals

Target: SANOFI (PORTFOLIO OF CONSUMER HEALTH BRANDS)

Bidder: STADA ARZNEIMITTEL AG

3 Service Providers

2 Bidder | 1 Vendor

28 Dealmakers

26 Bidder | 2 Vendor

n/a

Value

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy